this patient population was not suitable to assess any effects of intraoperative b-blockers on immune function. In both groups, intraoperative doses of metoprolol were administered to blunt tachycardia unresponsive to top-up doses of anaesthetics, but the use of b-blockers did not differ between the groups. Hence the concept that intraoperative b-blockade may have contributed to the inhibition of the proinflammatory response is not supported by our results. A more detailed description of the cardiovascular effects of S-(+)-ketamine in comparison with sufentanil as the main analgesic in a similar patient group has been published before.
Pressure recording analytical method to measure cardiac output after cardiac surgery: some practical considerations Editor-We read with interest the paper 'Lack of agreement between pulmonary arterial thermodilution cardiac output and the pressure recording analytical method in postoperative cardiac surgery patients'. 1 The study aimed to determine the reliability of pressure recording analytical method (PRAM)-derived cardiac output (PRAM-CO) in comparison with thermodilution-derived CO (ThD-CO) in a heterogeneous group of patients after cardiac surgery. Large differences between PRAM-CO and ThD-CO were found and the authors concluded that PRAM-CO could not replace ThD-CO in such patients. The authors sought explanations for the discrepancies between their work and previous studies showing the accuracy of PRAM to measure CO when compared with ThD-CO.
2 -4 We wish to share some considerations that may help to clarify this issue. First, pressure artifacts are a common phenomenon that must be addressed whenever using pulse contour methods (PCMs) to estimate CO. In fact, different catheter -transducer systems for arterial waveform transmission could give different results in terms of measured pressures.
5 PRAM analyses the arterial signal using a sampling frequency of 1000 Hz. The high-frequency sampling permits a better precision, which is of primary importance for the calculation of the arterial impedance and the correct measurement of pressures. Indeed, in case of an eventual resonance effect of the catheter -transducer system, the device allows to adapt its setting to maximize the signal-to-noise ratio. A pressure waveform altered by under-damping might affect both the amplitude and morphology of the signal evaluated by PRAM5. If resonance occurs, dP/dtmax provided by PRAM is abnormally high, reflecting the poor quality of the arterial trace. In this situation, PRAM could likely overestimate systolic arterial pressure and stroke volume. Conversely, there could be under-estimation in the case of over-damped signals. Indeed, PRAM is more sensitive to artifacts than other PCMs as its algorithm is exclusively based on the analysis of the pressure wave morphology and not on external (e.g. bolus dilution) or internal pre-estimated parameters. 4 In their article, 1 the authors have not provided sufficient information concerning pressure signal quality, stroke volume, and systolic arterial pressure values, which could help to evaluate whether these confounding factors may have influenced CO measurement. Secondly, when comparing a PCM with bolus thermodilution, for each determination of ThD-CO, a corresponding value for PCM must be obtained by averaging the CO obtained by individual beats over the time needed for the reference method estimation. 6 In their study, 1 the average of three 1 min continuous registrations with 1 min intervals was taken (5 min total period) for PRAM, but the authors did not explain how the average of individual beats within 1 min intervals was calculated (i.e. Visually? Downloading the data by the transfer-card?). Also, ThD-CO was calculated as the mean of at least three separate measurements obtained over a total period of 3 min. It appears that the time interval used for PRAM-CO measurement did not match the interval for ThD-CO calculation. Although this may be acceptable for extremely stable patients, it is a methodological limitation of the study.
Thirdly, the characteristics of the arterial tree, such as pathological changes in the ascending aorta, and aortic valve disease might alter the shape of the arterial pressure wave and influence the accuracy of a PCM. Even though the unreliability of PRAM in such patients has still to be demonstrated, these conditions were considered as exclusion criteria in the previous studies with PRAM. Conversely, 11 of 27 patients (41%) with such pathologies were enrolled. PRAM has shown good reliability to estimate CO in several clinical situations, including cardiac surgery. When this device is used for scientific research, investigators should take into appropriate account the possible pitfalls and limitations, as it happens for all the other technologies. We believe that statements concerning the quality of the arterial pressure signal, and interventions to improve it, should be clearly described in studies validating PCMs. This is often missing in the literature and, inappropriately, also in our previous studies. Therefore, we strongly recommend providing this information in future research on PCMs.
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2
Dr Scolletta and colleagues criticize that we 'did not provide sufficient information concerning pressure signal quality, nor stroke volume and systolic arterial pressure values, which could help to evaluate whether the aforementioned confounding factors may have influenced CO measurements'. We have to admit that we did not present individual details on stroke volume and arterial pressure. However, we note that these details also cannot be derived from their own publications 2 3 and that this might be helpful to explore the reliability of a pulse-contour measurement.
They suggest that 'the time interval used for PRAM-CO measurement did not match the interval for ThD-CO
